Loading...
Core Laboratories N.V.
CLB•NYSE
Energy
Oil & Gas Equipment & Services
$11.73
$-1.63(-12.20%)
Core Laboratories N.V. (CLB) Financial Performance & Income Statement Overview
Review Core Laboratories N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.76%
↑ 2.76%
Operating Income Growth
7.17%
↑ 7.17%
Net Income Growth
-14.38%
↓ 14.38%
Operating Cash Flow Growth
127.47%
↑ 127.47%
Operating Margin
10.38%
↑ 10.38%
Gross Margin
16.71%
↑ 16.71%
Net Profit Margin
5.73%
↑ 5.73%
ROE
11.58%
↑ 11.58%
ROIC
10.79%
↑ 10.79%
Core Laboratories N.V. (CLB) Income Statement & Financial Overview
Review Core Laboratories N.V.'s (CLB) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $123.58M | $129.24M | $134.40M | $130.58M |
| Cost of Revenue | $103.19M | $109.86M | $110.48M | $106.70M |
| Gross Profit | $20.40M | $19.37M | $23.92M | $23.88M |
| Gross Profit Ratio | $0.17 | $0.15 | $0.18 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $13.65M | $9.08M | $8.33M | $9.97M |
| Operating Expenses | $13.65M | $5.20M | $8.64M | $10.26M |
| Total Costs & Expenses | $119.17M | $115.06M | $115.45M | $116.96M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $2.60M | $2.63M | $3.11M | $3.21M |
| Depreciation & Amortization | $0.00 | $3.66M | $3.68M | $3.77M |
| EBITDA | $8.10M | $17.84M | $23.48M | $17.39M |
| EBITDA Ratio | $0.07 | $0.14 | $0.17 | $0.13 |
| Operating Income | $4.42M | $14.17M | $19.80M | $13.62M |
| Operating Income Ratio | $0.04 | $0.11 | $0.15 | $0.10 |
| Other Income/Expenses (Net) | -$2.60M | -$2.63M | -$3.11M | -$3.21M |
| Income Before Tax | $1.81M | $11.54M | $16.70M | $12.80M |
| Income Before Tax Ratio | $0.01 | $0.09 | $0.12 | $0.10 |
| Income Tax Expense | $1.75M | $4.08M | $4.69M | $3.61M |
| Net Income | -$154000.00 | $7.40M | $11.74M | $9.03M |
| Net Income Ratio | -$0.001 | $0.06 | $0.09 | $0.07 |
| EPS | -$0.003 | $0.15 | $0.25 | $0.19 |
| Diluted EPS | -$0.003 | $0.15 | $0.25 | $0.19 |
| Weighted Avg Shares Outstanding | $46.77M | $47.77M | $46.92M | $46.91M |
| Weighted Avg Shares Outstanding (Diluted) | $46.77M | $47.77M | $47.82M | $47.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan